Lowe DB - Search Results

1

Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.

Kennedy RC, Shearer MH, Lowe DB, Jumper CA, Chiriva-Internati M, Bright RK. Kennedy RC, et al. Among authors: lowe db. Cancer Immunol Immunother. 2004 Nov;53(11):987-94. doi: 10.1007/s00262-004-0547-3. Epub 2004 May 19. Cancer Immunol Immunother. 2004. PMID: 15156293 Free PMC article.

2

In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.

Lowe DB, Shearer MH, Tarbox JA, Kang HS, Jumper CA, Bright RK, Kennedy RC. Lowe DB, et al. Virology. 2005 Feb 5;332(1):28-37. doi: 10.1016/j.virol.2004.08.041. Virology. 2005. PMID: 15661138 Free article.

3

DNA vaccines: successes and limitations in cancer and infectious disease.

Lowe DB, Shearer MH, Kennedy RC. Lowe DB, et al. J Cell Biochem. 2006 May 15;98(2):235-42. doi: 10.1002/jcb.20775. J Cell Biochem. 2006. PMID: 16440328 Review.

4

Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases.

Lowe DB, Shearer MH, Jumper CA, Bright RK, Kennedy RC. Lowe DB, et al. J Virol. 2007 Feb;81(3):1313-8. doi: 10.1128/JVI.01943-06. Epub 2006 Nov 15. J Virol. 2007. PMID: 17108042 Free PMC article.

5

SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen.

Lowe DB, Shearer MH, Jumper CA, Kennedy RC. Lowe DB, et al. Cell Mol Life Sci. 2007 Apr;64(7-8):803-14. doi: 10.1007/s00018-007-6414-6. Cell Mol Life Sci. 2007. PMID: 17260087 Review.

6

A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17.

Chiriva-Internati M, Grizzi F, Weidanz JA, Ferrari R, Yuefei Y, Velez B, Shearer MH, Lowe DB, Frezza EE, Cobos E, Kast WM, Kennedy RC. Chiriva-Internati M, et al. Among authors: lowe db. J Immunol Methods. 2007 Apr 10;321(1-2):86-93. doi: 10.1016/j.jim.2007.01.010. Epub 2007 Feb 9. J Immunol Methods. 2007. PMID: 17336323

7

Towards progress on DNA vaccines for cancer.

Lowe DB, Shearer MH, Jumper CA, Kennedy RC. Lowe DB, et al. Cell Mol Life Sci. 2007 Sep;64(18):2391-403. doi: 10.1007/s00018-007-7165-0. Cell Mol Life Sci. 2007. PMID: 17565444 Review.

8

Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.

Lowe DB, Shearer MH, Jumper CA, Bright RK, Kennedy RC. Lowe DB, et al. J Virol. 2010 Jan;84(2):883-93. doi: 10.1128/JVI.01512-09. Epub 2009 Nov 4. J Virol. 2010. PMID: 19889780 Free PMC article.

9

Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.

Lowe DB, Shearer MH, Aldrich JF, Winn RE, Jumper CA, Kennedy RC. Lowe DB, et al. J Virol. 2010 Oct;84(19):10121-30. doi: 10.1128/JVI.01095-10. Epub 2010 Jul 28. J Virol. 2010. PMID: 20668083 Free PMC article.

10

Vaccines and immunotherapeutics for the treatment of malignant disease.

Aldrich JF, Lowe DB, Shearer MH, Winn RE, Jumper CA, Kennedy RC. Aldrich JF, et al. Among authors: lowe db. Clin Dev Immunol. 2010;2010:697158. doi: 10.1155/2010/697158. Epub 2010 Sep 26. Clin Dev Immunol. 2010. PMID: 20936120 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page